{"id":"45d3d734-4612-4acd-93a4-8687ab7e94ca","kind":"companies","code":"UB-C5576","name":"Aureka Biotechnologies","nameBasis":"source-english","summary":"Antibody drug discovery driven by generative AI and digital biology","description":"","country":null,"category":null,"originalName":"Aureka Biotechnologies","eventDate":null,"website":"https://www.aurekabio.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:23:30.014Z","reviewedAt":"2026-10-20T18:23:30.014Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"3bd42e5b778768ce4e8c1f0761b984ee7ceb9b5700c511566f259d9de0713575","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"生成式 AI 与数字生物学驱动的抗体药物发现","sources":[],"related":[{"id":"884503b6-b4e3-4a09-a195-674d61f07198","kind":"institutions","code":"UB-I1572","name":"Agentic Ventures","nameBasis":"original-brand","summary":"An early-stage venture capital firm focused on AI agents.","description":"An early-stage venture capital firm focused on AI agents.","country":"Singapore","category":null,"originalName":"Agentic Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:17.915Z","englishUpdatedAt":"2026-10-20T18:26:56.957Z","reviewedAt":"2026-10-20T18:26:56.957Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"e4d39e0570629189eeaa60065b44b39a8416de7ecc4cb91a2292eff2e306dbe6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/agentic-ventures"},{"id":"92b2de7e-1b71-444b-81d1-7b560c8913c6","kind":"news","code":"92b2de7e-1b71-444b-81d1-7b560c8913c6","name":"Aureka Biotechnologies raises tens of millions of USD in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Aureka Biotechnologies完成数千万美元A轮融资","eventDate":"2025-11-10T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-13T16:57:22.821Z","englishUpdatedAt":"2026-10-15T17:19:59.743Z","reviewedAt":"2026-10-15T17:19:59.743Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"84a2442c0dfa60900e3229f90f9e51cbbad2e0c9ea0eeff3049c3598a94b0821","companyId":"45d3d734-4612-4acd-93a4-8687ab7e94ca","foundedYear":null,"logoUrl":null,"path":"/news/92b2de7e-1b71-444b-81d1-7b560c8913c6"},{"id":"f6faa94b-ac7b-488d-9432-df41acc518b5","kind":"news","code":"f6faa94b-ac7b-488d-9432-df41acc518b5","name":"Aureka Biotechnologies raises USD 35 million in Series A+ financing","nameBasis":"translated-title","summary":"On 2026-04-28, according to Xiniu Data, Aureka Biotechnologies completed Series A+ financing, raising USD 35 million. Investors were lead investor Hongshan China, Jingwei Venture Capital, Boyuan Capital, Wuyuan Capital and others. The company is a developer of antibody drugs using generative AI.","description":"","country":null,"category":null,"originalName":"Aureka Biotechnologies完成A+轮融资，金额3500万美元","eventDate":"2026-04-28T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-19T06:08:30.047Z","englishUpdatedAt":"2026-10-20T18:23:00.946Z","reviewedAt":"2026-10-20T18:23:00.946Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"b37c987502d3629b428e3864f097d2be526d46e092b53faa85b5821f625d3bf1","companyId":"45d3d734-4612-4acd-93a4-8687ab7e94ca","foundedYear":null,"logoUrl":null,"path":"/news/f6faa94b-ac7b-488d-9432-df41acc518b5"},{"id":"da8ff968-58e4-459a-a4ea-5c1dfdef62e8","kind":"institutions","code":"UB-I254","name":"Granite Asia","nameBasis":"original-brand","summary":"An Asian private equity investment firm focused on growth and acquisition investments.","description":"An Asian private equity investment firm focused on growth and acquisition investments.","country":"Hong Kong, China","category":null,"originalName":"Granite Asia","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.838Z","englishUpdatedAt":"2026-10-20T18:27:03.788Z","reviewedAt":"2026-10-20T18:27:03.788Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"471e515eea3ae3b3f7084ae5e68efc714c944bc4112ecb175f09c6e38e6d22c9","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/granite-asia"},{"id":"9c76fb30-02ff-4e90-8a49-7affc195e15f","kind":"institutions","code":"UB-I022","name":"Hongshan China","nameBasis":"transliterated","summary":"The China branch of leading global venture capital firm Sequoia Capital, covering TMT, consumer businesses, healthcare, and AI, with notable investments including ByteDance, Meituan, Pinduoduo, and JD.com.","description":"The China branch of leading global venture capital firm Sequoia Capital, covering TMT, consumer businesses, healthcare, and AI, with notable investments including ByteDance, Meituan, Pinduoduo, and JD.com.","country":null,"category":null,"originalName":"红杉中国","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.320Z","englishUpdatedAt":"2026-10-15T21:44:38.216Z","reviewedAt":"2026-10-15T21:44:38.216Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a2c7ecf34846fd8e589f711ac888475c5c3cea4f3df39b6b1905d9cbaadeb827","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hongshan-china"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"},{"id":"3cf52c95-d578-4c3c-ad48-9b19ff63a715","kind":"news","code":"3cf52c95-d578-4c3c-ad48-9b19ff63a715","name":"Xunming Shengke raises USD 100 million in Series B funding, bringing total funding close to USD 200 million","nameBasis":"translated-title","summary":"On 2026/8/11, Elsewhere reported that Chinese biological AI company Xunming Shengke raised USD 100 million in Series B funding, bringing total funding close to USD 200 million. The round was completed in stages, with proceeds supporting biological foundation model R&D and training at scale.","description":"","country":null,"category":null,"originalName":"寻明生科完成1亿美元B轮融资，累计融资近2亿美元","eventDate":"2026-08-11T00:00:00.000Z","website":"https://elsewhere.news/zh/5ycapital/1bai-5y-news","sourceUpdatedAt":"2026-10-20T04:04:20.832Z","englishUpdatedAt":"2026-10-20T18:31:08.162Z","reviewedAt":"2026-10-20T18:31:08.162Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"41731cd43e2cabfd009fd98bdbd92e611841cc27546f22b5f7a0052f9ac5afaf","companyId":"45d3d734-4612-4acd-93a4-8687ab7e94ca","foundedYear":null,"logoUrl":null,"path":"/news/3cf52c95-d578-4c3c-ad48-9b19ff63a715"},{"id":"ff7d41a5-b7cd-44a1-a23b-bc9e082639a4","kind":"institutions","code":"UB-I016","name":"五源资本","nameBasis":"transliterated","summary":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","description":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","country":null,"category":null,"originalName":"五源资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.242Z","englishUpdatedAt":"2026-10-15T21:43:23.741Z","reviewedAt":"2026-10-15T21:43:23.741Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7368ba44c3815996c52f9d8d28ae59336c59aa7539208a5ef5949f6cc0f793e0","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wuyuan Capital","path":"/institutions/wuyuan-capital"},{"id":"d201fb3f-4316-4750-8c23-69214a9dec41","kind":"institutions","code":"UB-I2854","name":"博远资本","nameBasis":"transliterated","summary":"A healthcare venture capital firm.","description":"A healthcare venture capital firm.","country":null,"category":null,"originalName":"博远资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:12:23.417Z","englishUpdatedAt":"2026-10-15T18:21:17.307Z","reviewedAt":"2026-10-15T18:21:17.307Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"079faf2646fb4cbaf7e703d4399ce7e80df58e151b4ce446979177f825b34c9c","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Boyuan Capital","path":"/institutions/UB-I2854"},{"id":"67e42b1e-f516-42b6-b582-0baea3db0b3c","kind":"institutions","code":"UB-I569","name":"弘晖基金","nameBasis":"transliterated","summary":"A Chinese healthcare private equity firm.","description":"A Chinese healthcare private equity firm.","country":null,"category":null,"originalName":"弘晖基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:25.567Z","englishUpdatedAt":"2026-10-15T18:21:17.103Z","reviewedAt":"2026-10-15T18:21:17.103Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"33dbc839341b04ebb741e0baf486a4cb25c9b64bcee3250bdab33579f97b7c06","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Honghui Fund","path":"/institutions/honghui-fund"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"纽尔利资本","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Niuerli Capital","path":"/institutions/niuerli-capital"},{"id":"9479d7c1-e67a-44d8-8e1e-7c02c9d1af7d","kind":"institutions","code":"UB-I209","name":"经纬创投","nameBasis":"transliterated","summary":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","description":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","country":null,"category":null,"originalName":"经纬创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.457Z","englishUpdatedAt":"2026-10-15T21:39:21.207Z","reviewedAt":"2026-10-15T21:39:21.207Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fc153d78fb297c01b8830bd5dec0843514a8205f64f028c590a92825203f7cc4","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jingwei Venture Capital","path":"/institutions/jingwei-venture-capital"}],"finance":{"funding":{"metric":"funding","count":3,"latest":{"value":100000000,"text":"1亿美元","date":"2026-08-11T00:00:00.000Z","round":"Series B","estimate":"$100M"},"years":[2026],"points":[{"year":2026,"date":"2026-04-28T00:00:00.000Z","round":"Series A+","value":35000000,"eventIds":["f6faa94b-ac7b-488d-9432-df41acc518b5"]},{"year":2026,"date":"2026-08-11T00:00:00.000Z","round":"Series B","value":100000000,"eventIds":["3cf52c95-d578-4c3c-ad48-9b19ff63a715"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"3cf52c95-d578-4c3c-ad48-9b19ff63a715","date":"2026-08-11T00:00:00.000Z","round":"Series B","amountText":"1亿美元","estimateUsd":100000000,"estimateLabel":"$100M","estimateNote":null,"investors":"Granite Asia 独家投资首轮；弘晖基金 跟投；启明创投、经纬创投、纽尔利资本（老股东）","institutions":[{"id":"da8ff968-58e4-459a-a4ea-5c1dfdef62e8","kind":"institutions","code":"UB-I254","name":"Granite Asia","nameBasis":"original-brand","summary":"An Asian private equity investment firm focused on growth and acquisition investments.","description":"An Asian private equity investment firm focused on growth and acquisition investments.","country":"Hong Kong, China","category":null,"originalName":"Granite Asia","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.838Z","englishUpdatedAt":"2026-10-20T18:27:03.788Z","reviewedAt":"2026-10-20T18:27:03.788Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"471e515eea3ae3b3f7084ae5e68efc714c944bc4112ecb175f09c6e38e6d22c9","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/granite-asia"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"},{"id":"67e42b1e-f516-42b6-b582-0baea3db0b3c","kind":"institutions","code":"UB-I569","name":"弘晖基金","nameBasis":"transliterated","summary":"A Chinese healthcare private equity firm.","description":"A Chinese healthcare private equity firm.","country":null,"category":null,"originalName":"弘晖基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:25.567Z","englishUpdatedAt":"2026-10-15T18:21:17.103Z","reviewedAt":"2026-10-15T18:21:17.103Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"33dbc839341b04ebb741e0baf486a4cb25c9b64bcee3250bdab33579f97b7c06","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Honghui Fund","path":"/institutions/honghui-fund"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"纽尔利资本","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Niuerli Capital","path":"/institutions/niuerli-capital"},{"id":"9479d7c1-e67a-44d8-8e1e-7c02c9d1af7d","kind":"institutions","code":"UB-I209","name":"经纬创投","nameBasis":"transliterated","summary":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","description":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","country":null,"category":null,"originalName":"经纬创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.457Z","englishUpdatedAt":"2026-10-15T21:39:21.207Z","reviewedAt":"2026-10-15T21:39:21.207Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fc153d78fb297c01b8830bd5dec0843514a8205f64f028c590a92825203f7cc4","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jingwei Venture Capital","path":"/institutions/jingwei-venture-capital"}],"newsUrl":"https://elsewhere.news/zh/5ycapital/1bai-5y-news","evidence":{"headline":"Xunming Shengke raises USD 100 million in Series B funding, bringing total funding close to USD 200 million","brief":"On 2026/8/11, Elsewhere reported that Chinese biological AI company Xunming Shengke raised USD 100 million in Series B funding, bringing total funding close to USD 200 million. The round was completed in stages, with proceeds supporting biological foundation model R&D and training at scale.","basis":"translated-source-brief","newsPath":"/news/3cf52c95-d578-4c3c-ad48-9b19ff63a715","sourceCount":1}},{"id":"f6faa94b-ac7b-488d-9432-df41acc518b5","date":"2026-04-28T00:00:00.000Z","round":"Series A+","amountText":"3500万美元","estimateUsd":35000000,"estimateLabel":"$35M","estimateNote":null,"investors":"红杉中国领投，经纬创投、博远资本、五源资本、启明创投、纽尔利资本等跟投","institutions":[{"id":"9c76fb30-02ff-4e90-8a49-7affc195e15f","kind":"institutions","code":"UB-I022","name":"Hongshan China","nameBasis":"transliterated","summary":"The China branch of leading global venture capital firm Sequoia Capital, covering TMT, consumer businesses, healthcare, and AI, with notable investments including ByteDance, Meituan, Pinduoduo, and JD.com.","description":"The China branch of leading global venture capital firm Sequoia Capital, covering TMT, consumer businesses, healthcare, and AI, with notable investments including ByteDance, Meituan, Pinduoduo, and JD.com.","country":null,"category":null,"originalName":"红杉中国","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.320Z","englishUpdatedAt":"2026-10-15T21:44:38.216Z","reviewedAt":"2026-10-15T21:44:38.216Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a2c7ecf34846fd8e589f711ac888475c5c3cea4f3df39b6b1905d9cbaadeb827","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hongshan-china"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"},{"id":"ff7d41a5-b7cd-44a1-a23b-bc9e082639a4","kind":"institutions","code":"UB-I016","name":"五源资本","nameBasis":"transliterated","summary":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","description":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","country":null,"category":null,"originalName":"五源资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.242Z","englishUpdatedAt":"2026-10-15T21:43:23.741Z","reviewedAt":"2026-10-15T21:43:23.741Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7368ba44c3815996c52f9d8d28ae59336c59aa7539208a5ef5949f6cc0f793e0","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wuyuan Capital","path":"/institutions/wuyuan-capital"},{"id":"d201fb3f-4316-4750-8c23-69214a9dec41","kind":"institutions","code":"UB-I2854","name":"博远资本","nameBasis":"transliterated","summary":"A healthcare venture capital firm.","description":"A healthcare venture capital firm.","country":null,"category":null,"originalName":"博远资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:12:23.417Z","englishUpdatedAt":"2026-10-15T18:21:17.307Z","reviewedAt":"2026-10-15T18:21:17.307Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"079faf2646fb4cbaf7e703d4399ce7e80df58e151b4ce446979177f825b34c9c","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Boyuan Capital","path":"/institutions/UB-I2854"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"纽尔利资本","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Niuerli Capital","path":"/institutions/niuerli-capital"},{"id":"9479d7c1-e67a-44d8-8e1e-7c02c9d1af7d","kind":"institutions","code":"UB-I209","name":"经纬创投","nameBasis":"transliterated","summary":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","description":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","country":null,"category":null,"originalName":"经纬创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.457Z","englishUpdatedAt":"2026-10-15T21:39:21.207Z","reviewedAt":"2026-10-15T21:39:21.207Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fc153d78fb297c01b8830bd5dec0843514a8205f64f028c590a92825203f7cc4","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jingwei Venture Capital","path":"/institutions/jingwei-venture-capital"}],"newsUrl":null,"evidence":{"headline":"Aureka Biotechnologies raises USD 35 million in Series A+ financing","brief":"On 2026-04-28, according to Xiniu Data, Aureka Biotechnologies completed Series A+ financing, raising USD 35 million. Investors were lead investor Hongshan China, Jingwei Venture Capital, Boyuan Capital, Wuyuan Capital and others. The company is a developer of antibody drugs using generative AI.","basis":"translated-source-brief","newsPath":"/news/f6faa94b-ac7b-488d-9432-df41acc518b5","sourceCount":0}},{"id":"92b2de7e-1b71-444b-81d1-7b560c8913c6","date":"2025-11-10T00:00:00.000Z","round":"Series A","amountText":"数千万美元","estimateUsd":null,"estimateLabel":"Tens of millions of US dollars","estimateNote":null,"investors":"五源资本,启明创投,纽尔利资本,Agentic Ventures","institutions":[{"id":"884503b6-b4e3-4a09-a195-674d61f07198","kind":"institutions","code":"UB-I1572","name":"Agentic Ventures","nameBasis":"original-brand","summary":"An early-stage venture capital firm focused on AI agents.","description":"An early-stage venture capital firm focused on AI agents.","country":"Singapore","category":null,"originalName":"Agentic Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:17.915Z","englishUpdatedAt":"2026-10-20T18:26:56.957Z","reviewedAt":"2026-10-20T18:26:56.957Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"e4d39e0570629189eeaa60065b44b39a8416de7ecc4cb91a2292eff2e306dbe6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/agentic-ventures"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"},{"id":"ff7d41a5-b7cd-44a1-a23b-bc9e082639a4","kind":"institutions","code":"UB-I016","name":"五源资本","nameBasis":"transliterated","summary":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","description":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","country":null,"category":null,"originalName":"五源资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.242Z","englishUpdatedAt":"2026-10-15T21:43:23.741Z","reviewedAt":"2026-10-15T21:43:23.741Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7368ba44c3815996c52f9d8d28ae59336c59aa7539208a5ef5949f6cc0f793e0","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wuyuan Capital","path":"/institutions/wuyuan-capital"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"纽尔利资本","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Niuerli Capital","path":"/institutions/niuerli-capital"}],"newsUrl":null,"evidence":{"headline":"Aureka Biotechnologies raises tens of millions of USD in Series A financing","brief":null,"basis":null,"newsPath":"/news/92b2de7e-1b71-444b-81d1-7b560c8913c6","sourceCount":0}}],"totalRaised":{"value":200000000,"label":"nearly $200M","date":"2026-08-11T00:00:00.000Z"}},"valuation":{"metric":"valuation","count":3,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":3,"records":[{"id":"3cf52c95-d578-4c3c-ad48-9b19ff63a715","date":"2026-08-11T00:00:00.000Z","round":"Series B","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"Granite Asia 独家投资首轮；弘晖基金 跟投；启明创投、经纬创投、纽尔利资本（老股东）","institutions":[{"id":"da8ff968-58e4-459a-a4ea-5c1dfdef62e8","kind":"institutions","code":"UB-I254","name":"Granite Asia","nameBasis":"original-brand","summary":"An Asian private equity investment firm focused on growth and acquisition investments.","description":"An Asian private equity investment firm focused on growth and acquisition investments.","country":"Hong Kong, China","category":null,"originalName":"Granite Asia","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.838Z","englishUpdatedAt":"2026-10-20T18:27:03.788Z","reviewedAt":"2026-10-20T18:27:03.788Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"471e515eea3ae3b3f7084ae5e68efc714c944bc4112ecb175f09c6e38e6d22c9","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/granite-asia"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"},{"id":"67e42b1e-f516-42b6-b582-0baea3db0b3c","kind":"institutions","code":"UB-I569","name":"弘晖基金","nameBasis":"transliterated","summary":"A Chinese healthcare private equity firm.","description":"A Chinese healthcare private equity firm.","country":null,"category":null,"originalName":"弘晖基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:25.567Z","englishUpdatedAt":"2026-10-15T18:21:17.103Z","reviewedAt":"2026-10-15T18:21:17.103Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"33dbc839341b04ebb741e0baf486a4cb25c9b64bcee3250bdab33579f97b7c06","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Honghui Fund","path":"/institutions/honghui-fund"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"纽尔利资本","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Niuerli Capital","path":"/institutions/niuerli-capital"},{"id":"9479d7c1-e67a-44d8-8e1e-7c02c9d1af7d","kind":"institutions","code":"UB-I209","name":"经纬创投","nameBasis":"transliterated","summary":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","description":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","country":null,"category":null,"originalName":"经纬创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.457Z","englishUpdatedAt":"2026-10-15T21:39:21.207Z","reviewedAt":"2026-10-15T21:39:21.207Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fc153d78fb297c01b8830bd5dec0843514a8205f64f028c590a92825203f7cc4","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jingwei Venture Capital","path":"/institutions/jingwei-venture-capital"}],"newsUrl":"https://elsewhere.news/zh/5ycapital/1bai-5y-news","evidence":{"headline":"Xunming Shengke raises USD 100 million in Series B funding, bringing total funding close to USD 200 million","brief":"On 2026/8/11, Elsewhere reported that Chinese biological AI company Xunming Shengke raised USD 100 million in Series B funding, bringing total funding close to USD 200 million. The round was completed in stages, with proceeds supporting biological foundation model R&D and training at scale.","basis":"translated-source-brief","newsPath":"/news/3cf52c95-d578-4c3c-ad48-9b19ff63a715","sourceCount":1}},{"id":"f6faa94b-ac7b-488d-9432-df41acc518b5","date":"2026-04-28T00:00:00.000Z","round":"Series A+","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"红杉中国领投，经纬创投、博远资本、五源资本、启明创投、纽尔利资本等跟投","institutions":[{"id":"9c76fb30-02ff-4e90-8a49-7affc195e15f","kind":"institutions","code":"UB-I022","name":"Hongshan China","nameBasis":"transliterated","summary":"The China branch of leading global venture capital firm Sequoia Capital, covering TMT, consumer businesses, healthcare, and AI, with notable investments including ByteDance, Meituan, Pinduoduo, and JD.com.","description":"The China branch of leading global venture capital firm Sequoia Capital, covering TMT, consumer businesses, healthcare, and AI, with notable investments including ByteDance, Meituan, Pinduoduo, and JD.com.","country":null,"category":null,"originalName":"红杉中国","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.320Z","englishUpdatedAt":"2026-10-15T21:44:38.216Z","reviewedAt":"2026-10-15T21:44:38.216Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a2c7ecf34846fd8e589f711ac888475c5c3cea4f3df39b6b1905d9cbaadeb827","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hongshan-china"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"},{"id":"ff7d41a5-b7cd-44a1-a23b-bc9e082639a4","kind":"institutions","code":"UB-I016","name":"五源资本","nameBasis":"transliterated","summary":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","description":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","country":null,"category":null,"originalName":"五源资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.242Z","englishUpdatedAt":"2026-10-15T21:43:23.741Z","reviewedAt":"2026-10-15T21:43:23.741Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7368ba44c3815996c52f9d8d28ae59336c59aa7539208a5ef5949f6cc0f793e0","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wuyuan Capital","path":"/institutions/wuyuan-capital"},{"id":"d201fb3f-4316-4750-8c23-69214a9dec41","kind":"institutions","code":"UB-I2854","name":"博远资本","nameBasis":"transliterated","summary":"A healthcare venture capital firm.","description":"A healthcare venture capital firm.","country":null,"category":null,"originalName":"博远资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:12:23.417Z","englishUpdatedAt":"2026-10-15T18:21:17.307Z","reviewedAt":"2026-10-15T18:21:17.307Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"079faf2646fb4cbaf7e703d4399ce7e80df58e151b4ce446979177f825b34c9c","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Boyuan Capital","path":"/institutions/UB-I2854"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"纽尔利资本","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Niuerli Capital","path":"/institutions/niuerli-capital"},{"id":"9479d7c1-e67a-44d8-8e1e-7c02c9d1af7d","kind":"institutions","code":"UB-I209","name":"经纬创投","nameBasis":"transliterated","summary":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","description":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","country":null,"category":null,"originalName":"经纬创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.457Z","englishUpdatedAt":"2026-10-15T21:39:21.207Z","reviewedAt":"2026-10-15T21:39:21.207Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fc153d78fb297c01b8830bd5dec0843514a8205f64f028c590a92825203f7cc4","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jingwei Venture Capital","path":"/institutions/jingwei-venture-capital"}],"newsUrl":null,"evidence":{"headline":"Aureka Biotechnologies raises USD 35 million in Series A+ financing","brief":"On 2026-04-28, according to Xiniu Data, Aureka Biotechnologies completed Series A+ financing, raising USD 35 million. Investors were lead investor Hongshan China, Jingwei Venture Capital, Boyuan Capital, Wuyuan Capital and others. The company is a developer of antibody drugs using generative AI.","basis":"translated-source-brief","newsPath":"/news/f6faa94b-ac7b-488d-9432-df41acc518b5","sourceCount":0}},{"id":"92b2de7e-1b71-444b-81d1-7b560c8913c6","date":"2025-11-10T00:00:00.000Z","round":"Series A","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"五源资本,启明创投,纽尔利资本,Agentic Ventures","institutions":[{"id":"884503b6-b4e3-4a09-a195-674d61f07198","kind":"institutions","code":"UB-I1572","name":"Agentic Ventures","nameBasis":"original-brand","summary":"An early-stage venture capital firm focused on AI agents.","description":"An early-stage venture capital firm focused on AI agents.","country":"Singapore","category":null,"originalName":"Agentic Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:17.915Z","englishUpdatedAt":"2026-10-20T18:26:56.957Z","reviewedAt":"2026-10-20T18:26:56.957Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"e4d39e0570629189eeaa60065b44b39a8416de7ecc4cb91a2292eff2e306dbe6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/agentic-ventures"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"},{"id":"ff7d41a5-b7cd-44a1-a23b-bc9e082639a4","kind":"institutions","code":"UB-I016","name":"五源资本","nameBasis":"transliterated","summary":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","description":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","country":null,"category":null,"originalName":"五源资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.242Z","englishUpdatedAt":"2026-10-15T21:43:23.741Z","reviewedAt":"2026-10-15T21:43:23.741Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7368ba44c3815996c52f9d8d28ae59336c59aa7539208a5ef5949f6cc0f793e0","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wuyuan Capital","path":"/institutions/wuyuan-capital"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"纽尔利资本","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Niuerli Capital","path":"/institutions/niuerli-capital"}],"newsUrl":null,"evidence":{"headline":"Aureka Biotechnologies raises tens of millions of USD in Series A financing","brief":null,"basis":null,"newsPath":"/news/92b2de7e-1b71-444b-81d1-7b560c8913c6","sourceCount":0}}]},"revenue":{"metric":"revenue","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"3cf52c95-d578-4c3c-ad48-9b19ff63a715","date":"2026-08-11T00:00:00.000Z","round":"Series B","amountText":"过去两年实现千万美元级商业收入","estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"Granite Asia 独家投资首轮；弘晖基金 跟投；启明创投、经纬创投、纽尔利资本（老股东）","institutions":[{"id":"da8ff968-58e4-459a-a4ea-5c1dfdef62e8","kind":"institutions","code":"UB-I254","name":"Granite Asia","nameBasis":"original-brand","summary":"An Asian private equity investment firm focused on growth and acquisition investments.","description":"An Asian private equity investment firm focused on growth and acquisition investments.","country":"Hong Kong, China","category":null,"originalName":"Granite Asia","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.838Z","englishUpdatedAt":"2026-10-20T18:27:03.788Z","reviewedAt":"2026-10-20T18:27:03.788Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"471e515eea3ae3b3f7084ae5e68efc714c944bc4112ecb175f09c6e38e6d22c9","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/granite-asia"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"},{"id":"67e42b1e-f516-42b6-b582-0baea3db0b3c","kind":"institutions","code":"UB-I569","name":"弘晖基金","nameBasis":"transliterated","summary":"A Chinese healthcare private equity firm.","description":"A Chinese healthcare private equity firm.","country":null,"category":null,"originalName":"弘晖基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:25.567Z","englishUpdatedAt":"2026-10-15T18:21:17.103Z","reviewedAt":"2026-10-15T18:21:17.103Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"33dbc839341b04ebb741e0baf486a4cb25c9b64bcee3250bdab33579f97b7c06","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Honghui Fund","path":"/institutions/honghui-fund"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"纽尔利资本","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Niuerli Capital","path":"/institutions/niuerli-capital"},{"id":"9479d7c1-e67a-44d8-8e1e-7c02c9d1af7d","kind":"institutions","code":"UB-I209","name":"经纬创投","nameBasis":"transliterated","summary":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","description":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","country":null,"category":null,"originalName":"经纬创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.457Z","englishUpdatedAt":"2026-10-15T21:39:21.207Z","reviewedAt":"2026-10-15T21:39:21.207Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fc153d78fb297c01b8830bd5dec0843514a8205f64f028c590a92825203f7cc4","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jingwei Venture Capital","path":"/institutions/jingwei-venture-capital"}],"newsUrl":"https://elsewhere.news/zh/5ycapital/1bai-5y-news","evidence":{"headline":"Xunming Shengke raises USD 100 million in Series B funding, bringing total funding close to USD 200 million","brief":"On 2026/8/11, Elsewhere reported that Chinese biological AI company Xunming Shengke raised USD 100 million in Series B funding, bringing total funding close to USD 200 million. The round was completed in stages, with proceeds supporting biological foundation model R&D and training at scale.","basis":"translated-source-brief","newsPath":"/news/3cf52c95-d578-4c3c-ad48-9b19ff63a715","sourceCount":1}}]}},"events":[{"id":"3cf52c95-d578-4c3c-ad48-9b19ff63a715","kind":"funding","eventDate":"2026-08-11T00:00:00.000Z","revenueDate":null,"round":"B轮","amountText":"1亿美元","valuationText":null,"revenueText":"过去两年实现千万美元级商业收入","cumulativeFundingText":"近2亿美元","amountEstimateUsd":100000000,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":200000000,"investors":"Granite Asia 独家投资首轮；弘晖基金 跟投；启明创投、经纬创投、纽尔利资本（老股东）","newsUrl":"https://elsewhere.news/zh/5ycapital/1bai-5y-news","newsTypes":["融资","收入"],"institutions":[{"id":"da8ff968-58e4-459a-a4ea-5c1dfdef62e8","kind":"institutions","code":"UB-I254","name":"Granite Asia","nameBasis":"original-brand","summary":"An Asian private equity investment firm focused on growth and acquisition investments.","description":"An Asian private equity investment firm focused on growth and acquisition investments.","country":"Hong Kong, China","category":null,"originalName":"Granite Asia","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.838Z","englishUpdatedAt":"2026-10-20T18:27:03.788Z","reviewedAt":"2026-10-20T18:27:03.788Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"471e515eea3ae3b3f7084ae5e68efc714c944bc4112ecb175f09c6e38e6d22c9","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/granite-asia"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"},{"id":"67e42b1e-f516-42b6-b582-0baea3db0b3c","kind":"institutions","code":"UB-I569","name":"弘晖基金","nameBasis":"transliterated","summary":"A Chinese healthcare private equity firm.","description":"A Chinese healthcare private equity firm.","country":null,"category":null,"originalName":"弘晖基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:25.567Z","englishUpdatedAt":"2026-10-15T18:21:17.103Z","reviewedAt":"2026-10-15T18:21:17.103Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"33dbc839341b04ebb741e0baf486a4cb25c9b64bcee3250bdab33579f97b7c06","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Honghui Fund","path":"/institutions/honghui-fund"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"纽尔利资本","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Niuerli Capital","path":"/institutions/niuerli-capital"},{"id":"9479d7c1-e67a-44d8-8e1e-7c02c9d1af7d","kind":"institutions","code":"UB-I209","name":"经纬创投","nameBasis":"transliterated","summary":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","description":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","country":null,"category":null,"originalName":"经纬创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.457Z","englishUpdatedAt":"2026-10-15T21:39:21.207Z","reviewedAt":"2026-10-15T21:39:21.207Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fc153d78fb297c01b8830bd5dec0843514a8205f64f028c590a92825203f7cc4","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jingwei Venture Capital","path":"/institutions/jingwei-venture-capital"}],"roundName":"Series B","amountLabel":"$100M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":"nearly $200M"},{"id":"f6faa94b-ac7b-488d-9432-df41acc518b5","kind":"funding","eventDate":"2026-04-28T00:00:00.000Z","revenueDate":null,"round":"A+轮","amountText":"3500万美元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":35000000,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"红杉中国领投，经纬创投、博远资本、五源资本、启明创投、纽尔利资本等跟投","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"9c76fb30-02ff-4e90-8a49-7affc195e15f","kind":"institutions","code":"UB-I022","name":"Hongshan China","nameBasis":"transliterated","summary":"The China branch of leading global venture capital firm Sequoia Capital, covering TMT, consumer businesses, healthcare, and AI, with notable investments including ByteDance, Meituan, Pinduoduo, and JD.com.","description":"The China branch of leading global venture capital firm Sequoia Capital, covering TMT, consumer businesses, healthcare, and AI, with notable investments including ByteDance, Meituan, Pinduoduo, and JD.com.","country":null,"category":null,"originalName":"红杉中国","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.320Z","englishUpdatedAt":"2026-10-15T21:44:38.216Z","reviewedAt":"2026-10-15T21:44:38.216Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a2c7ecf34846fd8e589f711ac888475c5c3cea4f3df39b6b1905d9cbaadeb827","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hongshan-china"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"},{"id":"ff7d41a5-b7cd-44a1-a23b-bc9e082639a4","kind":"institutions","code":"UB-I016","name":"五源资本","nameBasis":"transliterated","summary":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","description":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","country":null,"category":null,"originalName":"五源资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.242Z","englishUpdatedAt":"2026-10-15T21:43:23.741Z","reviewedAt":"2026-10-15T21:43:23.741Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7368ba44c3815996c52f9d8d28ae59336c59aa7539208a5ef5949f6cc0f793e0","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wuyuan Capital","path":"/institutions/wuyuan-capital"},{"id":"d201fb3f-4316-4750-8c23-69214a9dec41","kind":"institutions","code":"UB-I2854","name":"博远资本","nameBasis":"transliterated","summary":"A healthcare venture capital firm.","description":"A healthcare venture capital firm.","country":null,"category":null,"originalName":"博远资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:12:23.417Z","englishUpdatedAt":"2026-10-15T18:21:17.307Z","reviewedAt":"2026-10-15T18:21:17.307Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"079faf2646fb4cbaf7e703d4399ce7e80df58e151b4ce446979177f825b34c9c","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Boyuan Capital","path":"/institutions/UB-I2854"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"纽尔利资本","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Niuerli Capital","path":"/institutions/niuerli-capital"},{"id":"9479d7c1-e67a-44d8-8e1e-7c02c9d1af7d","kind":"institutions","code":"UB-I209","name":"经纬创投","nameBasis":"transliterated","summary":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","description":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","country":null,"category":null,"originalName":"经纬创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.457Z","englishUpdatedAt":"2026-10-15T21:39:21.207Z","reviewedAt":"2026-10-15T21:39:21.207Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fc153d78fb297c01b8830bd5dec0843514a8205f64f028c590a92825203f7cc4","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jingwei Venture Capital","path":"/institutions/jingwei-venture-capital"}],"roundName":"Series A+","amountLabel":"$35M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null},{"id":"92b2de7e-1b71-444b-81d1-7b560c8913c6","kind":"funding","eventDate":"2025-11-10T00:00:00.000Z","revenueDate":null,"round":"A轮","amountText":"数千万美元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"五源资本,启明创投,纽尔利资本,Agentic Ventures","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"884503b6-b4e3-4a09-a195-674d61f07198","kind":"institutions","code":"UB-I1572","name":"Agentic Ventures","nameBasis":"original-brand","summary":"An early-stage venture capital firm focused on AI agents.","description":"An early-stage venture capital firm focused on AI agents.","country":"Singapore","category":null,"originalName":"Agentic Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:17.915Z","englishUpdatedAt":"2026-10-20T18:26:56.957Z","reviewedAt":"2026-10-20T18:26:56.957Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"e4d39e0570629189eeaa60065b44b39a8416de7ecc4cb91a2292eff2e306dbe6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/agentic-ventures"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"},{"id":"ff7d41a5-b7cd-44a1-a23b-bc9e082639a4","kind":"institutions","code":"UB-I016","name":"五源资本","nameBasis":"transliterated","summary":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","description":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","country":null,"category":null,"originalName":"五源资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.242Z","englishUpdatedAt":"2026-10-15T21:43:23.741Z","reviewedAt":"2026-10-15T21:43:23.741Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7368ba44c3815996c52f9d8d28ae59336c59aa7539208a5ef5949f6cc0f793e0","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wuyuan Capital","path":"/institutions/wuyuan-capital"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"纽尔利资本","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Niuerli Capital","path":"/institutions/niuerli-capital"}],"roundName":"Series A","amountLabel":"Tens of millions of US dollars","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[],"productsRelated":[],"investors":[{"id":"884503b6-b4e3-4a09-a195-674d61f07198","kind":"institutions","code":"UB-I1572","name":"Agentic Ventures","nameBasis":"original-brand","summary":"An early-stage venture capital firm focused on AI agents.","description":"An early-stage venture capital firm focused on AI agents.","country":"Singapore","category":null,"originalName":"Agentic Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:17.915Z","englishUpdatedAt":"2026-10-20T18:26:56.957Z","reviewedAt":"2026-10-20T18:26:56.957Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"e4d39e0570629189eeaa60065b44b39a8416de7ecc4cb91a2292eff2e306dbe6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/agentic-ventures"},{"id":"da8ff968-58e4-459a-a4ea-5c1dfdef62e8","kind":"institutions","code":"UB-I254","name":"Granite Asia","nameBasis":"original-brand","summary":"An Asian private equity investment firm focused on growth and acquisition investments.","description":"An Asian private equity investment firm focused on growth and acquisition investments.","country":"Hong Kong, China","category":null,"originalName":"Granite Asia","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.838Z","englishUpdatedAt":"2026-10-20T18:27:03.788Z","reviewedAt":"2026-10-20T18:27:03.788Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"471e515eea3ae3b3f7084ae5e68efc714c944bc4112ecb175f09c6e38e6d22c9","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/granite-asia"},{"id":"9c76fb30-02ff-4e90-8a49-7affc195e15f","kind":"institutions","code":"UB-I022","name":"Hongshan China","nameBasis":"transliterated","summary":"The China branch of leading global venture capital firm Sequoia Capital, covering TMT, consumer businesses, healthcare, and AI, with notable investments including ByteDance, Meituan, Pinduoduo, and JD.com.","description":"The China branch of leading global venture capital firm Sequoia Capital, covering TMT, consumer businesses, healthcare, and AI, with notable investments including ByteDance, Meituan, Pinduoduo, and JD.com.","country":null,"category":null,"originalName":"红杉中国","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.320Z","englishUpdatedAt":"2026-10-15T21:44:38.216Z","reviewedAt":"2026-10-15T21:44:38.216Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a2c7ecf34846fd8e589f711ac888475c5c3cea4f3df39b6b1905d9cbaadeb827","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hongshan-china"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"},{"id":"ff7d41a5-b7cd-44a1-a23b-bc9e082639a4","kind":"institutions","code":"UB-I016","name":"五源资本","nameBasis":"transliterated","summary":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","description":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","country":null,"category":null,"originalName":"五源资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.242Z","englishUpdatedAt":"2026-10-15T21:43:23.741Z","reviewedAt":"2026-10-15T21:43:23.741Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7368ba44c3815996c52f9d8d28ae59336c59aa7539208a5ef5949f6cc0f793e0","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wuyuan Capital","path":"/institutions/wuyuan-capital"},{"id":"d201fb3f-4316-4750-8c23-69214a9dec41","kind":"institutions","code":"UB-I2854","name":"博远资本","nameBasis":"transliterated","summary":"A healthcare venture capital firm.","description":"A healthcare venture capital firm.","country":null,"category":null,"originalName":"博远资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:12:23.417Z","englishUpdatedAt":"2026-10-15T18:21:17.307Z","reviewedAt":"2026-10-15T18:21:17.307Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"079faf2646fb4cbaf7e703d4399ce7e80df58e151b4ce446979177f825b34c9c","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Boyuan Capital","path":"/institutions/UB-I2854"},{"id":"67e42b1e-f516-42b6-b582-0baea3db0b3c","kind":"institutions","code":"UB-I569","name":"弘晖基金","nameBasis":"transliterated","summary":"A Chinese healthcare private equity firm.","description":"A Chinese healthcare private equity firm.","country":null,"category":null,"originalName":"弘晖基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:25.567Z","englishUpdatedAt":"2026-10-15T18:21:17.103Z","reviewedAt":"2026-10-15T18:21:17.103Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"33dbc839341b04ebb741e0baf486a4cb25c9b64bcee3250bdab33579f97b7c06","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Honghui Fund","path":"/institutions/honghui-fund"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"纽尔利资本","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Niuerli Capital","path":"/institutions/niuerli-capital"},{"id":"9479d7c1-e67a-44d8-8e1e-7c02c9d1af7d","kind":"institutions","code":"UB-I209","name":"经纬创投","nameBasis":"transliterated","summary":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","description":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","country":null,"category":null,"originalName":"经纬创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.457Z","englishUpdatedAt":"2026-10-15T21:39:21.207Z","reviewedAt":"2026-10-15T21:39:21.207Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fc153d78fb297c01b8830bd5dec0843514a8205f64f028c590a92825203f7cc4","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jingwei Venture Capital","path":"/institutions/jingwei-venture-capital"}],"path":"/companies/aureka-biotechnologies","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":null},"definition":"Aureka Biotechnologies is a company.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/companies/aureka-biotechnologies"}